Over the past decade, the gut microbiota has received considerable attention for its
interactions with the host. Microbial β-glucuronidase generated by this community has …

Broad‐spectrum antibiotics target multiple gram‐positive and gram‐negative bacteria, and
can collaterally damage the gut microbiota. Yet, our knowledge of the extent of damage, the …

The human gut microbiome harbors hundreds of bacterial species with diverse biochemical
capabilities. Dozens of drugs have been shown to be metabolized by single isolates from …

Organ transplantation is a life-saving treatment for patients with end-stage disease, but
survival rates after transplantation vary considerably. There is now increasing evidence that …

Irinotecan treats a range of solid tumors, but its effectiveness is severely limited by
gastrointestinal (GI) tract toxicity caused by gut bacterial β-glucuronidase (GUS) enzymes …

The gut microbiome shapes local and systemic immunity. The liver is presumed to be a
protected sterile site. As such, a hepatic microbiome has not been examined. Here, we …

Gut commensals help shape and mold host immune system and deeply influence human
health. The disease spectrum of mankind that gut microbiome may associate with is ever …

The gut microbiome harbors trillions of organisms that contribute to human health and
disease. These bacteria can also affect the properties of medical drugs used to treat these …

Background Understanding the interactions between the gut microbiome and psychotropic
medications (psycho-pharmacomicrobiomics) could improve treatment stratification …

Our understanding of the involvement of the gut microbiota (GM) in human health has
expanded exponentially over the last few decades, particularly in the fields of metabolism …